Médecine

Paramédical

Autres domaines


S'abonner

Anti-fungal susceptibility and virulence factors of Candida spp. isolated from blood cultures - 23/11/19

Doi : 10.1016/j.mycmed.2019.08.001 
C. Sriphannam a, N. Nuanmuang b, K. Saengsawang c, D. Amornthipayawong d, A. Kummasook b,
a Department of Biochemistry, Faculty of Medical Science, Naresuan University, 65000 Phitsanulok, Thailand 
b Division of Clinical Microbiology and Parasitology, Department of Medical Technology, School of Allied Health Sciences, University of Phayao, 56000 Phayao, Thailand 
c Clinical Pathology, Lampang Hospital, 280, Phahon Yothin Road, 52000 Muang Lampang, Thailand 
d Laboratory of Microbiology, Medical Technology Unit, Nan Hospital, 55000 Nan, Thailand 

Corresponding author.

Highlights

The distribution of Candida spp. isolated from blood cultures of Lampang hospital, Thailand included C. albicans, C. tropicalis, C. parapsilosis, C. glabrata and C. guilliermondii, with the percentage of 44.1, 35.7, 9.5, 7.1 and 3.6, respectively.
All clinical isolates of C. albicans were still susceptible to fluconazole, whereas some non-albicans Candida (NAC) exhibited the resistance to fluconazole. However, both C. albicans and NAC isolates exhibited susceptibility to amphotericin B.
Virulence factor detection revealed that C. albicans predominantly had phospholipase, proteinase and esterase activity. C. tropicalis had a predominance of esterase, while C. glabrata and C. guilliermondii had no phospholipase and proteinase activity. Biofilm-forming ability, NAC produced a biofilm at a higher rate than C. albicans.

Le texte complet de cet article est disponible en PDF.

Abstract

Candidemia is one of the most common fungal nosocomial infections worldwide. It causes high mortality and morbidity rate with significant hospital costs due to increased length of hospital stay and costs for anti-fungal treatment. This study aims to investigate anti-fungal drug susceptibility, enzymatic activity and biofilm formation of the Candida spp. isolated from blood cultures. In 2016, a total of 84 clinical Candida isolates were analyzed for minimum inhibitory concentration (MIC) against fluconazole and amphotericin B by agar diffusion E-test (E-strips). Three enzymatic activity tests for phospholipase, proteinase and esterase were performed by using egg yolk agar, bovine serum albumin medium and Tween 80 opacity medium, respectively. Biofilm formation was determined by crystal violet staining. To describing the various Candida distributions cultured, C. albicans was the most frequent species (n=37, 44.1%), followed by C. tropicalis (n=30, 35.7%), C. parapsilosis (n=8, 9.5%), C. glabrata (n=6, 7.1%) and C. guilliermondii (n=3, 3.6%). Regarding anti-fungal drug susceptibility, C. albicans was susceptible to fluconazole (100%). In addition, all clinical Candida isolates were fully susceptible to amphotericin B (100%). The predominant enzyme activity of C. albicans included medium to high levels of phospholipase, proteinase and esterase activities. C. tropicalis displayed esterase activity, while C. glabrata and C. guilliermondii had no phospholipase and proteinase activity. Non-albicans Candida (NAC) i.e. C. tropicalis formed a biofilm at a higher rate than C. albicans. This study revealed the production of virulent factors in Candida strains from candidemia patients.

Le texte complet de cet article est disponible en PDF.

Keywords : Candida albicans, Non-albicans Candida, Biofilm, Virulence factors


Plan


© 2019  Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 29 - N° 4

P. 325-330 - décembre 2019 Retour au numéro
Article précédent Article précédent
  • Candidemia in a Portuguese tertiary care hospital: Analysis of a 2-year period
  • S. Pinto-Magalhães, A. Martins, S. Lacerda, R. Filipe, B. Prista-Leão, D. Pinheiro, A. Silva-Pinto, L. Santos
| Article suivant Article suivant
  • Inhibition of the growth of human dermatophytic pathogens by selected australian and asian plants traditionally used to treat fungal infections
  • W. Noé, S. Murhekar, A. White, C. Davis, I.E. Cock

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement ou un achat à l’unité.

Déjà abonné à cette revue ?

;

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.